MENU
+Compare
LPTX
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$0.26
Change
-$0.02 (-7.14%)
Capitalization
11.44M

LPTX Leap Therapeutics Forecast, Technical & Fundamental Analysis

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells... Show more

Industry: #Biotechnology
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for LPTX with price predictions
Jun 27, 2025

LPTX sees MACD Histogram crosses below signal line

LPTX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 17, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 33 instances where the indicator turned negative. In of the 33 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 18, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LPTX as a result. In of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

LPTX moved below its 50-day moving average on June 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LPTX crossed bearishly below the 50-day moving average on June 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LPTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LPTX advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

LPTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 156 cases where LPTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.520) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). LPTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. LPTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LPTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

LPTX is expected to report earnings to fall 76.22% to -8 cents per share on August 11

Leap Therapeutics LPTX Stock Earnings Reports
Q2'23
Est.
$-0.09
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.33
Q1'23
Missed
by $0.23
Q4'22
Est.
$-0.11
The last earnings report on May 13 showed earnings per share of -37 cents, beating the estimate of -40 cents. With 1.02M shares outstanding, the current market capitalization sits at 11.44M.
A.I. Advisor
published General Information

General Information

a company, which engages in clinical stage immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
54
Web
https://www.leaptx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNO38.450.99
+2.64%
CNO Financial Group
BOLT5.61N/A
N/A
Bolt Biotherapeutics Inc
STLD131.21-0.29
-0.22%
Steel Dynamics
IMTX5.43-0.16
-2.86%
Immatics NV
NTIC7.85-0.41
-4.96%
Northern Technologies International Corp

LPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with SABS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then SABS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-6.47%
SABS - LPTX
48%
Loosely correlated
-5.06%
INKT - LPTX
42%
Loosely correlated
-6.31%
EVAX - LPTX
30%
Poorly correlated
-5.41%
PLRX - LPTX
29%
Poorly correlated
-3.08%
ALLR - LPTX
29%
Poorly correlated
+2.12%
More